tiprankstipranks
Redcare Pharmacy (SHPPF)
OTHER OTC:SHPPF
US Market

Redcare Pharmacy (SHPPF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SHPPF Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Redcare
Pharmacy
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHPPF Stock 12 Month Forecast

Average Price Target

$108.75
▲(67.82% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is $108.75 with a high forecast of $134.06 and a low forecast of $86.27. The average price target represents a 67.82% change from the last price of $64.80.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"40":"$40","135":"$135","63.75":"$63.8","87.5":"$87.5","111.25":"$111.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":134.0624,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$134.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":108.74875428571428,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$108.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86.26624,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$86.27</span>\n  </div></div>","useHTML":true}}],"tickPositions":[40,63.75,87.5,111.25,135],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.8,70.12787692307693,75.45575384615384,80.78363076923077,86.1115076923077,91.43938461538461,96.76726153846154,102.09513846153845,107.42301538461538,112.75089230769231,118.07876923076923,123.40664615384615,128.73452307692307,{"y":134.0624,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.8,68.1806734065934,71.56134681318682,74.94202021978022,78.32269362637362,81.70336703296704,85.08404043956044,88.46471384615384,91.84538725274726,95.22606065934066,98.60673406593406,101.98740747252748,105.36808087912088,{"y":108.74875428571428,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.8,66.45124923076922,68.10249846153846,69.75374769230768,71.40499692307692,73.05624615384615,74.70749538461538,76.35874461538461,78.00999384615385,79.66124307692307,81.31249230769231,82.96374153846153,84.61499076923076,{"y":86.26624,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":112.205,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.59,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.055,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.92,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.27,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.506,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.555,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.14,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.98,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.24,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.8,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$134.06Average Price Target$108.75Lowest Price Target$86.27
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$96.76$113.08
Buy
74.50%
Upside
Reiterated
08/26/26
Jefferies Keeps Their Buy Rating on Redcare Pharmacy (0RJT)
Barclays
$99.09
Buy
52.92%
Upside
Assigned
08/12/26
Barclays Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
UBS
$69.95$86.27
Hold
33.13%
Upside
Reiterated
07/31/26
UBS Remains a Hold on Redcare Pharmacy (0RJT)
Deutsche Bank  Analyst forecast on SHPPF
Deutsche Bank
Deutsche Bank
$118.91$120.07
Buy
85.30%
Upside
Reiterated
07/31/26
Redcare Pharmacy (0RJT) Receives a Buy from Deutsche Bank
Berenberg Bank Analyst forecast on SHPPF
Berenberg Bank
Berenberg Bank
$107.25$109.58
Buy
69.11%
Upside
Reiterated
07/30/26
Berenberg Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Warburg Research Analyst forecast on SHPPF
Warburg Research
Warburg Research
$134.06
Buy
106.89%
Upside
Reiterated
07/29/26
Redcare Pharmacy (0RJT) Receives a Buy from Warburg Research
Baader Bank Analyst forecast on SHPPF
Baader Bank
Baader Bank
$99.09
Buy
52.92%
Upside
Reiterated
07/29/26
Redcare Pharmacy (0RJT) Receives a Buy from Baader Bank
Kepler Capital  Analyst forecast on SHPPF
Kepler Capital
Kepler Capital
$46.63
Hold
-28.04%
Downside
Reiterated
05/06/26
Kepler Capital Remains a Hold on Redcare Pharmacy (0RJT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$96.76$113.08
Buy
74.50%
Upside
Reiterated
08/26/26
Jefferies Keeps Their Buy Rating on Redcare Pharmacy (0RJT)
Barclays
$99.09
Buy
52.92%
Upside
Assigned
08/12/26
Barclays Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
UBS
$69.95$86.27
Hold
33.13%
Upside
Reiterated
07/31/26
UBS Remains a Hold on Redcare Pharmacy (0RJT)
Deutsche Bank  Analyst forecast on SHPPF
Deutsche Bank
Deutsche Bank
$118.91$120.07
Buy
85.30%
Upside
Reiterated
07/31/26
Redcare Pharmacy (0RJT) Receives a Buy from Deutsche Bank
Berenberg Bank Analyst forecast on SHPPF
Berenberg Bank
Berenberg Bank
$107.25$109.58
Buy
69.11%
Upside
Reiterated
07/30/26
Berenberg Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Warburg Research Analyst forecast on SHPPF
Warburg Research
Warburg Research
$134.06
Buy
106.89%
Upside
Reiterated
07/29/26
Redcare Pharmacy (0RJT) Receives a Buy from Warburg Research
Baader Bank Analyst forecast on SHPPF
Baader Bank
Baader Bank
$99.09
Buy
52.92%
Upside
Reiterated
07/29/26
Redcare Pharmacy (0RJT) Receives a Buy from Baader Bank
Kepler Capital  Analyst forecast on SHPPF
Kepler Capital
Kepler Capital
$46.63
Hold
-28.04%
Downside
Reiterated
05/06/26
Kepler Capital Remains a Hold on Redcare Pharmacy (0RJT)
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Redcare Pharmacy

3 Months
Jan KochDeutsche Bank
Success Rate
20/37 ratings generated profit
54%
Average Return
+0.29%
Copying Jan Koch's trades and holding each position for 3 Months would result in 54.05% of your transactions generating a profit, with an average return of +0.29% per trade.
1 Year
Jan KochDeutsche Bank
Success Rate
18/37 ratings generated profit
49%
Average Return
+6.34%
Copying Jan Koch's trades and holding each position for 1 Year would result in 48.65% of your transactions generating a profit, with an average return of +6.34% per trade.
2 Years
Gerhard OrgonasBerenberg Bank
Success Rate
21/46 ratings generated profit
46%
Average Return
+56.03%
Copying Gerhard Orgonas's trades and holding each position for 2 Years would result in 45.65% of your transactions generating a profit, with an average return of +56.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHPPF Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
12
16
12
13
8
Buy
1
2
5
10
11
Hold
5
7
6
4
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
25
23
27
21
In the current month, SHPPF has received 19 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. SHPPF average Analyst price target in the past 3 months is 108.75.
Each month's total comprises the sum of three months' worth of ratings.

SHPPF Financial Forecast

SHPPF Earnings Forecast

Next quarter’s earnings estimate for SHPPF is $0.08 with a range of $0.08 to $0.08. The previous quarter’s EPS was $0.26. SHPPF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year SHPPF has Outperformed its overall industry.
Next quarter’s earnings estimate for SHPPF is $0.08 with a range of $0.08 to $0.08. The previous quarter’s EPS was $0.26. SHPPF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year SHPPF has Outperformed its overall industry.

SHPPF Sales Forecast

Next quarter’s sales forecast for SHPPF is $955.60M with a range of $952.77M to $958.44M. The previous quarter’s sales results were $986.76M. SHPPF beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year SHPPF has Outperformed its overall industry.
Next quarter’s sales forecast for SHPPF is $955.60M with a range of $952.77M to $958.44M. The previous quarter’s sales results were $986.76M. SHPPF beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year SHPPF has Outperformed its overall industry.

SHPPF Stock Forecast FAQ

What is SHPPF’s average 12-month price target, according to analysts?
Based on analyst ratings, Redcare Pharmacy’s 12-month average price target is 108.75.
    What is SHPPF’s upside potential, based on the analysts’ average price target?
    Redcare Pharmacy has 67.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SHPPF a Buy, Sell or Hold?
          Redcare Pharmacy has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Redcare Pharmacy’s price target?
            The average price target for Redcare Pharmacy is 108.75. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $134.06 ,the lowest forecast is $86.27. The average price target represents 67.82% Increase from the current price of $64.8.
              What do analysts say about Redcare Pharmacy?
              Redcare Pharmacy’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of SHPPF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.